Synairgen's Founders

Synairgen is
a respiratory drug development company with a particular focus
on lung antiviral defence in asthma, COPD and severe viral infections

 
Share price

Click above to open the London Stock Exchange website for the latest share price information
More

Latest report & accounts

Copies of our Report and Accounts can be found here
More

About us

Find out more about Synairgen, its Directors and Founders
More

Holding(s) in Company 
22 July 2014  |  More

Holding(s) in Company 
22 July 2014  |  More

Holding(s) in Company 
22 July 2014  |  More

Holding(s) in Company 
21 July 2014  |  More

Holding(s) in Company 
16 July 2014  |  More

 

Holding(s) in Company 
15 July 2014  |  More

Placing 
04 July 2014  |  More

Holding(s) in Company 
04 July 2014  |  More

Holding in Company 
25 June 2014  |  More

AstraZeneca licence deal 
12 June 2014  |  More

 
 
 
 
 
 

Synairgen plc

Registered in England and Wales No. 5233429

 

 

Registered office

Mailpoint 810, Level F, South Block,
Southampton General Hospital, Tremona Road,
Southampton, SO16 6YD, UK